5: Biotransformation, Pharmacogenomics, Clinical Drug Trials Flashcards

1
Q

Drug biotransformation

A

The enzymatic process where once substance is changed to another

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

General idea for eliminating compounds via biotransformation

A

Make the compound more polar + sometimes larger

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Three consequences of biotransformation of a drug

A
  1. Inactivates
  2. Becomes a different active compound
  3. Activates a prodrug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

First pass effect

A

Process by which oral drugs undergo extensive biotransformation after absorption prior to entering circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Example of a drug that must be given parenterally bc of how much is lost during first pass effect

A

Morphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Phase 1 vs 2: which is anabolic and which is catabolic (generally)

A

Phase 1: catabolic

Phase 2: anabolic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

After phase 1 reaction, are substances generally more or less toxic and reactive?

A

More toxic and reactive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Major enzymes that act in phase 1 reactions

A

Monooxygenases, cytochrome P450, epoxide hydrolases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What CPY carries out metabolism of 50% of human drugs?**

A

CYP3A4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Examples of enzyme inducers

A

Phenobarbital, ethanol, aromatic hydrocarbons like tobacco smoke, rifampin, St. John’s wort

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What happens when acetaminophen exceeds therapeutic doses

A

Glucuronidation and sulfation pathways are saturated -> P450 is more and more important -> hepatic GSH is depleted faster than its regenerated -> toxic metabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Risk for poor metabolizers vs ultrafast metabolizers

A

Poor: accumulation of toxic drug levels
Fast: undertreated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Most common disease-producing enzyme defect of humans

A

G6PD deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does G6PD do and what happens when its defective/deficient?

A

G6PD: produces NADPH -> regenerates glutathione
Without: hemolytic anemia occurs in the presence of oxidants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What happens in a ryanodine receptor mutation with inhalation anesthetics like succ?

A

Increases Ca in sarcoplasm -> muscle rigidity -> high body temp and rhabdo-> malignant hyperthermia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What CYP acts on S-warfarin, phenytoin, and NSAIDs?

A

CYP2C9

17
Q

What does Vitamin K epoxide reductase complex subunit 1 (VKORC1) do?

A

Is the target of warfarin

18
Q

Lead compound

A

Chemical with pharmacological activity whose structure is used as a starting point for chemical mods in order to improve potency, selectivity, or pharmacokinetic parameters

19
Q

No-effect dose

A

The max dose at which a specified toxic effect is not seen

20
Q

Minimum vs median lethal dose

A

Minimum lethal dose: smallest dose observed to kill an experimental animal
Medial lethal dose: dose that kills about 50% of the animals

21
Q

Surrogate endpoint

A

Outcome of therapy that predicts the real goal of therapy without being that actual goal (ex: measuring LDL levels instead of cardiac events)